Effectiveness and safety of ranibizumab in a university hospital

Autores

DOI:

https://doi.org/10.22563/2525-7323.2022.v7.n.3.p.22-28

Palavras-chave:

Efetividade, Segurança, Ranibizumabe

Resumo

Purpose: To evaluate the effectiveness and safety of ranibizumab in the treatment of retinal diseases in a university hospital. Methods: Data from patients treated with ranibizumab were collected through participant interviews and medical records. The main measures of effectiveness were variations in visual acuity (VA) and changes in central retinal thickness (CRT). All adverse events that occurred during treatment were recorded for safety assessment. Results: A total of 103 patients, representing 154 eyes, were included in the study. The mean variation in VA was a loss of 0.9 letters on the ETDRS scale, and the mean variation in the CRT was a reduction of 12.6 µm. Conclusions: Considering the relatively limited changes in VA and CRT measurements, ranibizumab showed a lower degree of effectiveness in the treatment of neovascular diseases of the retinas. Low quantity and the interval between applications may have contributed significantly to the low effectiveness. The vast majority of adverse events reported were related to the medication application procedure.

Downloads

Publicado

2024-08-28

Como Citar

Ribeiro, D., & de Araújo Costa Beisl Noblat, L. (2024). Effectiveness and safety of ranibizumab in a university hospital. JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA, 7(3). https://doi.org/10.22563/2525-7323.2022.v7.n.3.p.22-28

Edição

v. 7 n. 3 (2022): JAFF

Seção

Articles

Licença

Copyright (c) 2024 DANIEL RIBEIRO, Lúcia Noblat

Creative Commons License
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.

Todo o conteúdo dos artigos publicados no JAFF está licenciado sob uma Licença Creative Commons Atribuição 4.0 Internacional, que permite o uso, compartilhamento, adaptação, distribuição e reprodução em qualquer meio ou formato, desde que você dê o devido crédito ao autor(es) original(ais) e a fonte, fornecer um link para a licença Creative Commons e indicar se alterações foram feitas. As imagens ou outros materiais de terceiros neste artigo estão incluídos na licença Creative Commons do artigo, salvo indicação em contrário em uma linha de crédito para o material.